

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to endosome (GO:0036010) | 4.12118444 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.05165961 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.05165961 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.05165961 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.05165961 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.05165961 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.05165961 |
| 8 | cell adhesion mediated by integrin (GO:0033627) | 3.82305664 |
| 9 | negative regulation of protein activation cascade (GO:2000258) | 3.82164721 |
| 10 | hypotonic response (GO:0006971) | 3.70889214 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 3.69816394 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 3.69816394 |
| 13 | negative regulation of complement activation (GO:0045916) | 3.63799600 |
| 14 | skin morphogenesis (GO:0043589) | 3.62032663 |
| 15 | COPII vesicle coating (GO:0048208) | 3.47127083 |
| 16 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.40547004 |
| 17 | growth hormone receptor signaling pathway (GO:0060396) | 3.38884616 |
| 18 | response to lipoprotein particle (GO:0055094) | 3.37303530 |
| 19 | regulation of complement activation (GO:0030449) | 3.33409915 |
| 20 | regulation of protein activation cascade (GO:2000257) | 3.30390558 |
| 21 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.27226351 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 3.25658178 |
| 23 | embryonic process involved in female pregnancy (GO:0060136) | 3.13108801 |
| 24 | nerve growth factor signaling pathway (GO:0038180) | 3.08566141 |
| 25 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.05757942 |
| 26 | negative regulation of humoral immune response (GO:0002921) | 3.05478550 |
| 27 | apoptotic cell clearance (GO:0043277) | 3.00598822 |
| 28 | central nervous system myelination (GO:0022010) | 2.98947762 |
| 29 | axon ensheathment in central nervous system (GO:0032291) | 2.98947762 |
| 30 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.93037660 |
| 31 | cellular response to growth hormone stimulus (GO:0071378) | 2.91904692 |
| 32 | positive regulation of macrophage cytokine production (GO:0060907) | 2.89455422 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 2.85372250 |
| 34 | desmosome organization (GO:0002934) | 2.85274620 |
| 35 | macroautophagy (GO:0016236) | 2.84402417 |
| 36 | low-density lipoprotein particle clearance (GO:0034383) | 2.83634494 |
| 37 | cortical actin cytoskeleton organization (GO:0030866) | 2.81742440 |
| 38 | substrate-dependent cell migration (GO:0006929) | 2.78275105 |
| 39 | myelin maintenance (GO:0043217) | 2.74879669 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 2.74622907 |
| 41 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.74142890 |
| 42 | stress fiber assembly (GO:0043149) | 2.72216740 |
| 43 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.70082158 |
| 44 | basement membrane organization (GO:0071711) | 2.69781254 |
| 45 | nuclear pore complex assembly (GO:0051292) | 2.69670004 |
| 46 | vesicle coating (GO:0006901) | 2.67629184 |
| 47 | positive regulation of p38MAPK cascade (GO:1900745) | 2.66679769 |
| 48 | semaphorin-plexin signaling pathway (GO:0071526) | 2.63509312 |
| 49 | cell-substrate junction assembly (GO:0007044) | 2.61856368 |
| 50 | response to laminar fluid shear stress (GO:0034616) | 2.61265386 |
| 51 | response to host immune response (GO:0052572) | 2.60003219 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60003219 |
| 53 | regulation of lipoprotein metabolic process (GO:0050746) | 2.58835515 |
| 54 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.58538358 |
| 55 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55021195 |
| 56 | regulation of macrophage cytokine production (GO:0010935) | 2.52506548 |
| 57 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.51815312 |
| 58 | response to nerve growth factor (GO:1990089) | 2.51815312 |
| 59 | cellular response to ethanol (GO:0071361) | 2.49189075 |
| 60 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.48965491 |
| 61 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.48938250 |
| 62 | complement activation, alternative pathway (GO:0006957) | 2.48852380 |
| 63 | regulation of apoptotic cell clearance (GO:2000425) | 2.48673986 |
| 64 | regulation of cholesterol homeostasis (GO:2000188) | 2.47159483 |
| 65 | creatine metabolic process (GO:0006600) | 2.46856614 |
| 66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.46054549 |
| 67 | response to host (GO:0075136) | 2.46054549 |
| 68 | response to host defenses (GO:0052200) | 2.46054549 |
| 69 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44119961 |
| 70 | cortical cytoskeleton organization (GO:0030865) | 2.44056218 |
| 71 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.42748989 |
| 72 | surfactant homeostasis (GO:0043129) | 2.41948326 |
| 73 | positive regulation of receptor recycling (GO:0001921) | 2.41448628 |
| 74 | negative regulation of fatty acid transport (GO:2000192) | 2.41333625 |
| 75 | plasma lipoprotein particle assembly (GO:0034377) | 2.40282596 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 2.40175901 |
| 77 | virion attachment to host cell (GO:0019062) | 2.40175901 |
| 78 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.39959510 |
| 79 | protein hydroxylation (GO:0018126) | 2.39637472 |
| 80 | negative regulation of anoikis (GO:2000811) | 2.38560648 |
| 81 | positive regulation of coagulation (GO:0050820) | 2.38334810 |
| 82 | regulation of cholesterol storage (GO:0010885) | 2.38222538 |
| 83 | extracellular matrix assembly (GO:0085029) | 2.37910051 |
| 84 | regulation of transforming growth factor beta production (GO:0071634) | 2.37583568 |
| 85 | positive regulation of blood coagulation (GO:0030194) | 2.37076618 |
| 86 | positive regulation of hemostasis (GO:1900048) | 2.37076618 |
| 87 | import into cell (GO:0098657) | 2.36201677 |
| 88 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.36121729 |
| 89 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.36050175 |
| 90 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.35644897 |
| 91 | lung lobe morphogenesis (GO:0060463) | 2.35591740 |
| 92 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.33491738 |
| 93 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.32030001 |
| 94 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.30753167 |
| 95 | wound healing, spreading of epidermal cells (GO:0035313) | 2.29600290 |
| 96 | chondrocyte development (GO:0002063) | 2.29354828 |
| 97 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.29317079 |
| 98 | axon ensheathment (GO:0008366) | 2.29191339 |
| 99 | ensheathment of neurons (GO:0007272) | 2.29191339 |
| 100 | I-kappaB phosphorylation (GO:0007252) | 2.28872768 |
| 101 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.28781227 |
| 102 | lipid translocation (GO:0034204) | 2.28675051 |
| 103 | phospholipid translocation (GO:0045332) | 2.28675051 |
| 104 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.28039877 |
| 105 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.26929684 |
| 106 | epithelial cell-cell adhesion (GO:0090136) | 2.26659015 |
| 107 | protein retention in ER lumen (GO:0006621) | 2.26075263 |
| 108 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.25712872 |
| 109 | protein-lipid complex assembly (GO:0065005) | 2.23410549 |
| 110 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23353652 |
| 111 | myelination (GO:0042552) | 2.23153284 |
| 112 | microglial cell activation (GO:0001774) | 2.22728482 |
| 113 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.22613387 |
| 114 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 2.22336376 |
| 115 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.21603410 |
| 116 | positive regulation of osteoblast proliferation (GO:0033690) | 2.21317014 |
| 117 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.20634169 |
| 118 | cellular response to interferon-alpha (GO:0035457) | 2.20423656 |
| 119 | glomerular visceral epithelial cell development (GO:0072015) | 2.20282432 |
| 120 | L-amino acid import (GO:0043092) | 2.19572414 |
| 121 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.19009761 |
| 122 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.18657613 |
| 123 | cellular copper ion homeostasis (GO:0006878) | 2.18561820 |
| 124 | regulation of fibrinolysis (GO:0051917) | 2.18275042 |
| 125 | hemidesmosome assembly (GO:0031581) | 2.17965438 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.17625259 |
| 127 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.16741923 |
| 128 | membrane protein ectodomain proteolysis (GO:0006509) | 2.15366623 |
| 129 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.15296450 |
| 130 | cellular response to vitamin D (GO:0071305) | 2.13023050 |
| 131 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.12920678 |
| 132 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.12766253 |
| 133 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.12427051 |
| 134 | renal filtration (GO:0097205) | 2.11579859 |
| 135 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.10592061 |
| 136 | axon extension involved in axon guidance (GO:0048846) | 2.10592061 |
| 137 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.09842283 |
| 138 | establishment of endothelial barrier (GO:0061028) | 2.09694388 |
| 139 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.09530986 |
| 140 | protein carboxylation (GO:0018214) | 2.09530986 |
| 141 | alpha-linolenic acid metabolic process (GO:0036109) | 2.09256861 |
| 142 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.09136508 |
| 143 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.09125842 |
| 144 | iron ion import (GO:0097286) | 2.09037294 |
| 145 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.08325375 |
| 146 | gap junction assembly (GO:0016264) | 2.07039794 |
| 147 | Rap protein signal transduction (GO:0032486) | 2.06486856 |
| 148 | bone remodeling (GO:0046849) | 2.06466597 |
| 149 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.06287247 |
| 150 | nuclear pore organization (GO:0006999) | 2.05971314 |
| 151 | neutrophil activation involved in immune response (GO:0002283) | 2.04920005 |
| 152 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.04093752 |
| 153 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.03862537 |
| 154 | regulation of p38MAPK cascade (GO:1900744) | 2.03823774 |
| 155 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.03625129 |
| 156 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.03365576 |
| 157 | adhesion of symbiont to host (GO:0044406) | 2.02998366 |
| 158 | wound healing, spreading of cells (GO:0044319) | 2.02902097 |
| 159 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.02752397 |
| 160 | asymmetric protein localization (GO:0008105) | 2.02693636 |
| 161 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.01708612 |
| 162 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.01474958 |
| 163 | positive regulation of bone remodeling (GO:0046852) | 2.00703661 |
| 164 | positive regulation of bone resorption (GO:0045780) | 2.00703661 |
| 165 | endodermal cell differentiation (GO:0035987) | 2.00653605 |
| 166 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.00459974 |
| 167 | clathrin coat assembly (GO:0048268) | 2.00112058 |
| 168 | positive regulation of histone deacetylation (GO:0031065) | 1.99996502 |
| 169 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.99706113 |
| 170 | membrane raft organization (GO:0031579) | 1.98526444 |
| 171 | glomerular epithelial cell development (GO:0072310) | 1.98072679 |
| 172 | regulation of hormone biosynthetic process (GO:0046885) | 1.97335829 |
| 173 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.96665771 |
| 174 | Golgi organization (GO:0007030) | 1.96039352 |
| 175 | endocardial cushion development (GO:0003197) | 1.95831958 |
| 176 | response to methylmercury (GO:0051597) | 1.94019342 |
| 177 | mesodermal cell differentiation (GO:0048333) | 1.93420319 |
| 178 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 1.92868288 |
| 179 | sodium ion export (GO:0071436) | 1.92855399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.19070652 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.06744142 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73618628 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.48051225 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.24041983 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.20469916 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.99167864 |
| 8 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.95444892 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.90216198 |
| 10 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.88105874 |
| 11 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.86322448 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.85818702 |
| 13 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.84268716 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83528171 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80251667 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78482083 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.77962610 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77076898 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74624370 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.69640007 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69011819 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67939110 |
| 23 | TP53_16413492_ChIP-PET_HCT116_Human | 1.62957038 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62573968 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59743287 |
| 26 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.58548703 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55949109 |
| 28 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55779738 |
| 29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55779738 |
| 30 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.55644907 |
| 31 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.55554375 |
| 32 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.54981827 |
| 33 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52901562 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.52474789 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51604019 |
| 36 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50870055 |
| 37 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50350990 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50137474 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.49754672 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.47079441 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46182137 |
| 42 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45336434 |
| 43 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42016527 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40325875 |
| 45 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37669903 |
| 46 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.37372617 |
| 47 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37015919 |
| 48 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.36949518 |
| 49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35247750 |
| 50 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33068167 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29271730 |
| 52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28653618 |
| 53 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28525645 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.24916114 |
| 55 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.23817696 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23745414 |
| 57 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23703486 |
| 58 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23407489 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23388818 |
| 60 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23101495 |
| 61 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22190850 |
| 62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21834046 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21611931 |
| 64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21416981 |
| 65 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20934070 |
| 66 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.20589678 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.20229312 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19716971 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19590700 |
| 70 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19040490 |
| 71 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18497925 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18340167 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17921684 |
| 74 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17461511 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17134394 |
| 76 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15755895 |
| 77 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15215622 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.14827313 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14800896 |
| 80 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14711978 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13829337 |
| 82 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.13562505 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13450006 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.13294469 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.13294469 |
| 86 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13145338 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12964326 |
| 88 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11215614 |
| 89 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.10733799 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10538970 |
| 91 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.10259954 |
| 92 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.09647654 |
| 93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09214180 |
| 94 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08741128 |
| 95 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08458555 |
| 96 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08314184 |
| 97 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.07407702 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06659130 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06120067 |
| 100 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.05955518 |
| 101 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04554718 |
| 102 | KDM2B_26808549_Chip-Seq_K562_Human | 1.03358748 |
| 103 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03131895 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03021667 |
| 105 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02926392 |
| 106 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02926392 |
| 107 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02561989 |
| 108 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01033651 |
| 109 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00867716 |
| 110 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00307615 |
| 111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00265979 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99389808 |
| 113 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.99293050 |
| 114 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99142504 |
| 115 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97889104 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97733628 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96520571 |
| 118 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95701795 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95082618 |
| 120 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94852141 |
| 121 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.94852141 |
| 122 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94782684 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94143104 |
| 124 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94102618 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93937599 |
| 126 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93208386 |
| 127 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.92958108 |
| 128 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92938309 |
| 129 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92930063 |
| 130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91892004 |
| 131 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.91525987 |
| 132 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.91217093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.96001575 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.55881548 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 2.87517438 |
| 4 | MP0003303_peritoneal_inflammation | 2.83409403 |
| 5 | MP0005167_abnormal_blood-brain_barrier | 2.67448479 |
| 6 | MP0004272_abnormal_basement_membrane | 2.56416000 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.34101309 |
| 8 | MP0000920_abnormal_myelination | 2.33564552 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.31700726 |
| 10 | MP0003690_abnormal_glial_cell | 2.20427571 |
| 11 | MP0000604_amyloidosis | 2.16067900 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.13104615 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.09021959 |
| 14 | MP0010678_abnormal_skin_adnexa | 2.03962889 |
| 15 | MP0001958_emphysema | 2.02344186 |
| 16 | MP0005623_abnormal_meninges_morphology | 2.00728571 |
| 17 | MP0005409_darkened_coat_color | 1.97411027 |
| 18 | MP0005451_abnormal_body_composition | 1.93497616 |
| 19 | MP0003045_fibrosis | 1.93038392 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.91348437 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.90885898 |
| 22 | MP0003091_abnormal_cell_migration | 1.87560992 |
| 23 | MP0005275_abnormal_skin_tensile | 1.86169519 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.84606111 |
| 25 | MP0004858_abnormal_nervous_system | 1.77628440 |
| 26 | MP0003329_amyloid_beta_deposits | 1.66187156 |
| 27 | MP0003075_altered_response_to | 1.62825002 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.58376402 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.54438681 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.52685171 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.51713243 |
| 32 | MP0000383_abnormal_hair_follicle | 1.46479935 |
| 33 | MP0003436_decreased_susceptibility_to | 1.45355684 |
| 34 | MP0003941_abnormal_skin_development | 1.44118143 |
| 35 | MP0002009_preneoplasia | 1.42342736 |
| 36 | MP0005171_absent_coat_pigmentation | 1.41034574 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.38998137 |
| 38 | MP0003634_abnormal_glial_cell | 1.38777476 |
| 39 | MP0000733_abnormal_muscle_development | 1.38611686 |
| 40 | MP0004130_abnormal_muscle_cell | 1.38561697 |
| 41 | MP0008260_abnormal_autophagy | 1.37304173 |
| 42 | MP0003828_pulmonary_edema | 1.34796311 |
| 43 | MP0001299_abnormal_eye_distance/ | 1.33088528 |
| 44 | MP0009278_abnormal_bone_marrow | 1.33015743 |
| 45 | MP0002254_reproductive_system_inflammat | 1.31055180 |
| 46 | MP0000858_altered_metastatic_potential | 1.30760198 |
| 47 | MP0000003_abnormal_adipose_tissue | 1.28810897 |
| 48 | MP0002933_joint_inflammation | 1.26795130 |
| 49 | MP0003279_aneurysm | 1.25391783 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.24370494 |
| 51 | MP0004883_abnormal_blood_vessel | 1.23851195 |
| 52 | MP0001879_abnormal_lymphatic_vessel | 1.22493232 |
| 53 | MP0003448_altered_tumor_morphology | 1.21488205 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.21379746 |
| 55 | MP0002896_abnormal_bone_mineralization | 1.19924645 |
| 56 | MP0006054_spinal_hemorrhage | 1.19063175 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.15850063 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.15709940 |
| 59 | MP0003868_abnormal_feces_composition | 1.15313742 |
| 60 | MP0005164_abnormal_response_to | 1.14780245 |
| 61 | MP0003252_abnormal_bile_duct | 1.13957367 |
| 62 | MP0002295_abnormal_pulmonary_circulatio | 1.13395964 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.12352098 |
| 64 | MP0001851_eye_inflammation | 1.11283032 |
| 65 | MP0002006_tumorigenesis | 1.10867069 |
| 66 | MP0005388_respiratory_system_phenotype | 1.10838544 |
| 67 | MP0002133_abnormal_respiratory_system | 1.10838544 |
| 68 | MP0005165_increased_susceptibility_to | 1.10828622 |
| 69 | MP0010368_abnormal_lymphatic_system | 1.10035413 |
| 70 | MP0004510_myositis | 1.07700474 |
| 71 | MP0005375_adipose_tissue_phenotype | 1.06840568 |
| 72 | MP0005023_abnormal_wound_healing | 1.06743093 |
| 73 | MP0004233_abnormal_muscle_weight | 1.05363082 |
| 74 | MP0006082_CNS_inflammation | 1.05140753 |
| 75 | MP0004947_skin_inflammation | 1.03742645 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.03046837 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.00738761 |
| 78 | MP0003183_abnormal_peptide_metabolism | 0.99450760 |
| 79 | MP0003724_increased_susceptibility_to | 0.99218586 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 0.98921641 |
| 81 | MP0003633_abnormal_nervous_system | 0.98289317 |
| 82 | MP0002419_abnormal_innate_immunity | 0.97636262 |
| 83 | MP0005166_decreased_susceptibility_to | 0.96849229 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.96467144 |
| 85 | MP0001849_ear_inflammation | 0.96225042 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.93787567 |
| 87 | MP0002086_abnormal_extraembryonic_tissu | 0.92816562 |
| 88 | MP0005408_hypopigmentation | 0.91726365 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.90273577 |
| 90 | MP0000537_abnormal_urethra_morphology | 0.90178319 |
| 91 | MP0001881_abnormal_mammary_gland | 0.89408323 |
| 92 | MP0000747_muscle_weakness | 0.86898365 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.86774980 |
| 94 | MP0005248_abnormal_Harderian_gland | 0.86403425 |
| 95 | MP0009840_abnormal_foam_cell | 0.86225729 |
| 96 | MP0000751_myopathy | 0.85997571 |
| 97 | MP0000627_abnormal_mammary_gland | 0.85072150 |
| 98 | MP0001666_abnormal_nutrient_absorption | 0.84757095 |
| 99 | MP0005621_abnormal_cell_physiology | 0.84560428 |
| 100 | MP0004036_abnormal_muscle_relaxation | 0.84319490 |
| 101 | MP0003115_abnormal_respiratory_system | 0.84310161 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.83801501 |
| 103 | MP0001177_atelectasis | 0.82854646 |
| 104 | MP0005365_abnormal_bile_salt | 0.82826809 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.81956885 |
| 106 | MP0000343_altered_response_to | 0.81631038 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.81557875 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.80960420 |
| 109 | MP0009053_abnormal_anal_canal | 0.80667702 |
| 110 | MP0005390_skeleton_phenotype | 0.80357902 |
| 111 | MP0008057_abnormal_DNA_replication | 0.79892660 |
| 112 | MP0001661_extended_life_span | 0.79882058 |
| 113 | MP0003632_abnormal_nervous_system | 0.79845394 |
| 114 | MP0005387_immune_system_phenotype | 0.78964582 |
| 115 | MP0001790_abnormal_immune_system | 0.78964582 |
| 116 | MP0003195_calcinosis | 0.77964730 |
| 117 | MP0003631_nervous_system_phenotype | 0.76343353 |
| 118 | MP0001614_abnormal_blood_vessel | 0.76323914 |
| 119 | MP0002168_other_aberrant_phenotype | 0.75680556 |
| 120 | MP0004043_abnormal_pH_regulation | 0.73630978 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.73518266 |
| 122 | MP0004087_abnormal_muscle_fiber | 0.73386384 |
| 123 | MP0000750_abnormal_muscle_regeneration | 0.73281242 |
| 124 | MP0009785_altered_susceptibility_to | 0.71976464 |
| 125 | MP0008775_abnormal_heart_ventricle | 0.71334875 |
| 126 | MP0002090_abnormal_vision | 0.70188315 |
| 127 | MP0010630_abnormal_cardiac_muscle | 0.69726929 |
| 128 | MP0000249_abnormal_blood_vessel | 0.69548994 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.69238466 |
| 130 | MP0002925_abnormal_cardiovascular_devel | 0.69203362 |
| 131 | MP0001915_intracranial_hemorrhage | 0.68513358 |
| 132 | MP0002060_abnormal_skin_morphology | 0.68297086 |
| 133 | MP0008004_abnormal_stomach_pH | 0.67745018 |
| 134 | MP0000428_abnormal_craniofacial_morphol | 0.66967697 |
| 135 | MP0001175_abnormal_lung_morphology | 0.66502972 |
| 136 | MP0003943_abnormal_hepatobiliary_system | 0.66020489 |
| 137 | MP0002796_impaired_skin_barrier | 0.64804032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 3.69753586 |
| 2 | Cerebral inclusion bodies (HP:0100314) | 3.68172758 |
| 3 | Insidious onset (HP:0003587) | 3.65114799 |
| 4 | Termporal pattern (HP:0011008) | 3.65114799 |
| 5 | Deep venous thrombosis (HP:0002625) | 3.25350065 |
| 6 | Flat acetabular roof (HP:0003180) | 3.15410606 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.14290310 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.09305697 |
| 9 | Mitral stenosis (HP:0001718) | 3.08578842 |
| 10 | Osteolytic defects of the hand bones (HP:0009699) | 3.07451077 |
| 11 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.07451077 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.03938642 |
| 13 | Cerebral aneurysm (HP:0004944) | 3.01692310 |
| 14 | Hematochezia (HP:0002573) | 2.93204788 |
| 15 | Arterial tortuosity (HP:0005116) | 2.84226346 |
| 16 | Shallow orbits (HP:0000586) | 2.76526755 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 2.63856961 |
| 18 | Vascular tortuosity (HP:0004948) | 2.59896589 |
| 19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.57286811 |
| 20 | Aortic dissection (HP:0002647) | 2.56470677 |
| 21 | Hypoplasia of the iris (HP:0007676) | 2.52455192 |
| 22 | Buphthalmos (HP:0000557) | 2.50559567 |
| 23 | Axonal loss (HP:0003447) | 2.49956088 |
| 24 | Difficulty running (HP:0009046) | 2.49557810 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49455616 |
| 26 | Persistence of primary teeth (HP:0006335) | 2.47917859 |
| 27 | Cardiovascular calcification (HP:0011915) | 2.47101543 |
| 28 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.46064491 |
| 29 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.46064491 |
| 30 | Aortic aneurysm (HP:0004942) | 2.43868801 |
| 31 | Papillary thyroid carcinoma (HP:0002895) | 2.43406313 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.43067843 |
| 33 | Vertebral compression fractures (HP:0002953) | 2.41540937 |
| 34 | Myocardial infarction (HP:0001658) | 2.40962400 |
| 35 | Macroorchidism (HP:0000053) | 2.40091635 |
| 36 | Supranuclear gaze palsy (HP:0000605) | 2.37945642 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 2.36163743 |
| 38 | Disinhibition (HP:0000734) | 2.33061846 |
| 39 | Mitral valve prolapse (HP:0001634) | 2.32020832 |
| 40 | Atrophic scars (HP:0001075) | 2.29918475 |
| 41 | Short nail (HP:0001799) | 2.29849649 |
| 42 | Broad metatarsal (HP:0001783) | 2.27498979 |
| 43 | Vascular calcification (HP:0004934) | 2.27193420 |
| 44 | Peritonitis (HP:0002586) | 2.26901905 |
| 45 | Periodontitis (HP:0000704) | 2.25341237 |
| 46 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.23743376 |
| 47 | Focal segmental glomerulosclerosis (HP:0000097) | 2.23364024 |
| 48 | Scapular winging (HP:0003691) | 2.22888196 |
| 49 | Dysostosis multiplex (HP:0000943) | 2.22732028 |
| 50 | Esophageal varix (HP:0002040) | 2.20721754 |
| 51 | Ankyloglossia (HP:0010296) | 2.18456433 |
| 52 | Asymmetry of the thorax (HP:0001555) | 2.18111283 |
| 53 | Amyloidosis (HP:0011034) | 2.15663994 |
| 54 | Complement deficiency (HP:0004431) | 2.15037158 |
| 55 | Onion bulb formation (HP:0003383) | 2.13911503 |
| 56 | Spondylolisthesis (HP:0003302) | 2.12291153 |
| 57 | Disproportionate tall stature (HP:0001519) | 2.12269025 |
| 58 | Abnormality of complement system (HP:0005339) | 2.11394317 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.11125316 |
| 60 | Apathy (HP:0000741) | 2.08996735 |
| 61 | Coarse hair (HP:0002208) | 2.08659662 |
| 62 | Abnormality of the acetabulum (HP:0003170) | 2.08648647 |
| 63 | Abnormality of macrophages (HP:0004311) | 2.06941695 |
| 64 | Vertebral arch anomaly (HP:0008438) | 2.06168532 |
| 65 | Thick nail (HP:0001805) | 2.04453309 |
| 66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.03370667 |
| 67 | Ulnar bowing (HP:0003031) | 2.02570286 |
| 68 | Increased CSF protein (HP:0002922) | 2.01437146 |
| 69 | Abnormal foot bone ossification (HP:0010675) | 1.97524555 |
| 70 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.94609649 |
| 71 | Neuronal loss in central nervous system (HP:0002529) | 1.94066575 |
| 72 | Gingival bleeding (HP:0000225) | 1.93718073 |
| 73 | Protrusio acetabuli (HP:0003179) | 1.93176879 |
| 74 | Turricephaly (HP:0000262) | 1.93015878 |
| 75 | Spinal cord lesions (HP:0100561) | 1.92408907 |
| 76 | Syringomyelia (HP:0003396) | 1.92408907 |
| 77 | Abnormal ossification of hand bones (HP:0005921) | 1.92318970 |
| 78 | Subacute progressive viral hepatitis (HP:0006572) | 1.90800265 |
| 79 | Abnormality of oral frenula (HP:0000190) | 1.90331878 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 1.90084801 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.90037216 |
| 82 | Mucopolysacchariduria (HP:0008155) | 1.90037216 |
| 83 | Aneurysm (HP:0002617) | 1.89436538 |
| 84 | Menorrhagia (HP:0000132) | 1.89368113 |
| 85 | Broad face (HP:0000283) | 1.88723535 |
| 86 | Peripheral demyelination (HP:0011096) | 1.88562856 |
| 87 | Fatigue (HP:0012378) | 1.88505414 |
| 88 | Blue sclerae (HP:0000592) | 1.88110761 |
| 89 | Tetraparesis (HP:0002273) | 1.86551362 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 1.84560201 |
| 91 | Ankle contracture (HP:0006466) | 1.83731727 |
| 92 | Thin bony cortex (HP:0002753) | 1.83530535 |
| 93 | Diminished motivation (HP:0000745) | 1.83262678 |
| 94 | Action tremor (HP:0002345) | 1.82358168 |
| 95 | Right ventricular cardiomyopathy (HP:0011663) | 1.80777701 |
| 96 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.80272182 |
| 97 | Striae distensae (HP:0001065) | 1.79340499 |
| 98 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.78400772 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 1.78121270 |
| 100 | Muscle fiber splitting (HP:0003555) | 1.77759232 |
| 101 | Fragile skin (HP:0001030) | 1.77698248 |
| 102 | Advanced eruption of teeth (HP:0006288) | 1.77243005 |
| 103 | Achilles tendon contracture (HP:0001771) | 1.76269206 |
| 104 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73873369 |
| 105 | Glomerulosclerosis (HP:0000096) | 1.73669314 |
| 106 | Hypobetalipoproteinemia (HP:0003563) | 1.73436662 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 1.73292614 |
| 108 | Glomerulonephritis (HP:0000099) | 1.73093174 |
| 109 | Skin nodule (HP:0200036) | 1.72487013 |
| 110 | Frequent falls (HP:0002359) | 1.71661260 |
| 111 | Wormian bones (HP:0002645) | 1.69780661 |
| 112 | Coxa vara (HP:0002812) | 1.69758453 |
| 113 | Thickened calvaria (HP:0002684) | 1.69556595 |
| 114 | Hammertoe (HP:0001765) | 1.69194844 |
| 115 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.68966586 |
| 116 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.68966586 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.68966586 |
| 118 | Cervical subluxation (HP:0003308) | 1.67616028 |
| 119 | Abnormal hand bone ossification (HP:0010660) | 1.66473743 |
| 120 | Hyperextensible skin (HP:0000974) | 1.66424142 |
| 121 | Thoracolumbar scoliosis (HP:0002944) | 1.66067908 |
| 122 | Joint laxity (HP:0001388) | 1.66014186 |
| 123 | Camptodactyly of toe (HP:0001836) | 1.65546739 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65168124 |
| 125 | Absent frontal sinuses (HP:0002688) | 1.64312830 |
| 126 | Abnormal vertebral ossification (HP:0100569) | 1.63204597 |
| 127 | Increased connective tissue (HP:0009025) | 1.62978159 |
| 128 | Abnormality of the nasal septum (HP:0000419) | 1.62580104 |
| 129 | Abnormality of the lumbar spine (HP:0100712) | 1.62534068 |
| 130 | Soft skin (HP:0000977) | 1.62488566 |
| 131 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.62285924 |
| 132 | Curly hair (HP:0002212) | 1.62239788 |
| 133 | Scanning speech (HP:0002168) | 1.62043442 |
| 134 | Cerebral hemorrhage (HP:0001342) | 1.62042322 |
| 135 | Hypoplastic ischia (HP:0003175) | 1.61916548 |
| 136 | Bronchomalacia (HP:0002780) | 1.61244749 |
| 137 | Wide nose (HP:0000445) | 1.59784959 |
| 138 | Rapidly progressive (HP:0003678) | 1.59507833 |
| 139 | Vertebral hypoplasia (HP:0008417) | 1.58857648 |
| 140 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.58857648 |
| 141 | Dislocated radial head (HP:0003083) | 1.58689458 |
| 142 | Hepatocellular carcinoma (HP:0001402) | 1.58439584 |
| 143 | Gingivitis (HP:0000230) | 1.58104112 |
| 144 | Ovoid vertebral bodies (HP:0003300) | 1.57490506 |
| 145 | Intention tremor (HP:0002080) | 1.57472128 |
| 146 | Bladder diverticulum (HP:0000015) | 1.56765507 |
| 147 | Overgrowth (HP:0001548) | 1.56206805 |
| 148 | Femoral bowing (HP:0002980) | 1.55778506 |
| 149 | Nephritis (HP:0000123) | 1.55682665 |
| 150 | Neonatal death (HP:0003811) | 1.55651075 |
| 151 | Joint hemorrhage (HP:0005261) | 1.55428555 |
| 152 | Loss of speech (HP:0002371) | 1.55067822 |
| 153 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.54851103 |
| 154 | Abnormality of the Achilles tendon (HP:0005109) | 1.52884864 |
| 155 | Spinal rigidity (HP:0003306) | 1.50782577 |
| 156 | Conjunctival telangiectasia (HP:0000524) | 1.50588153 |
| 157 | Distal upper limb amyotrophy (HP:0007149) | 1.50276779 |
| 158 | Upper limb amyotrophy (HP:0009129) | 1.50276779 |
| 159 | Congenital glaucoma (HP:0001087) | 1.50112046 |
| 160 | Tibial bowing (HP:0002982) | 1.49185125 |
| 161 | Metabolic alkalosis (HP:0200114) | 1.48015768 |
| 162 | Aplasia involving bones of the extremities (HP:0009825) | 1.47074582 |
| 163 | Aplasia of the phalanges of the hand (HP:0009802) | 1.47074582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB1 | 4.21954571 |
| 2 | STK39 | 3.10439272 |
| 3 | TRIB3 | 2.77678573 |
| 4 | TTN | 2.69410230 |
| 5 | EPHA2 | 2.29415194 |
| 6 | RIPK1 | 2.24382911 |
| 7 | CAMK1G | 2.02446456 |
| 8 | CAMK1D | 1.96623515 |
| 9 | AKT3 | 1.96411758 |
| 10 | DMPK | 1.90467097 |
| 11 | SIK1 | 1.86953416 |
| 12 | PTK6 | 1.82449538 |
| 13 | MAP3K2 | 1.79222426 |
| 14 | EPHA3 | 1.78790362 |
| 15 | ICK | 1.74035969 |
| 16 | WNK4 | 1.72586109 |
| 17 | LATS2 | 1.72070639 |
| 18 | LATS1 | 1.62199574 |
| 19 | MET | 1.56428722 |
| 20 | FGFR2 | 1.50992533 |
| 21 | IRAK3 | 1.50952512 |
| 22 | EEF2K | 1.50623270 |
| 23 | PDGFRA | 1.45801331 |
| 24 | DDR2 | 1.43073670 |
| 25 | FER | 1.41959705 |
| 26 | SCYL2 | 1.39059495 |
| 27 | BMX | 1.38834461 |
| 28 | KSR2 | 1.37619674 |
| 29 | NTRK1 | 1.37215882 |
| 30 | WNK1 | 1.36732564 |
| 31 | OXSR1 | 1.35204496 |
| 32 | FGR | 1.33607323 |
| 33 | RET | 1.28039821 |
| 34 | YES1 | 1.27360646 |
| 35 | PDGFRB | 1.26207408 |
| 36 | PKN2 | 1.24391393 |
| 37 | FRK | 1.23045939 |
| 38 | JAK1 | 1.22273773 |
| 39 | TGFBR2 | 1.22035086 |
| 40 | STK38 | 1.18997313 |
| 41 | SGK3 | 1.18253523 |
| 42 | MAP2K3 | 1.17514594 |
| 43 | MAPKAPK5 | 1.14788808 |
| 44 | BRD4 | 1.13938327 |
| 45 | FGFR3 | 1.13667544 |
| 46 | JAK3 | 1.12547763 |
| 47 | PRKD3 | 1.06764084 |
| 48 | STK38L | 1.06709490 |
| 49 | MAP3K6 | 1.05872450 |
| 50 | FGFR4 | 1.05025949 |
| 51 | PRPF4B | 1.01514951 |
| 52 | LRRK2 | 1.01293722 |
| 53 | TRPM7 | 1.00941098 |
| 54 | KSR1 | 1.00522653 |
| 55 | PTK2 | 0.97092954 |
| 56 | STK24 | 0.96607736 |
| 57 | MELK | 0.93304907 |
| 58 | IRAK1 | 0.93023464 |
| 59 | TIE1 | 0.92943479 |
| 60 | ERN1 | 0.92564623 |
| 61 | GSK3A | 0.91373015 |
| 62 | PAK2 | 0.90346480 |
| 63 | PKN1 | 0.90089067 |
| 64 | PDPK1 | 0.89761902 |
| 65 | MAP3K1 | 0.88729730 |
| 66 | RIPK4 | 0.88619525 |
| 67 | PIK3CG | 0.88488727 |
| 68 | LMTK2 | 0.88204718 |
| 69 | PIK3CA | 0.87522028 |
| 70 | PRKD1 | 0.87145256 |
| 71 | ROCK2 | 0.86986995 |
| 72 | PTK2B | 0.86894768 |
| 73 | PAK3 | 0.86030032 |
| 74 | TYK2 | 0.85669543 |
| 75 | SGK2 | 0.85619861 |
| 76 | PRKCH | 0.85459405 |
| 77 | STK10 | 0.81252629 |
| 78 | STK3 | 0.80962873 |
| 79 | NLK | 0.79425432 |
| 80 | PAK6 | 0.78919243 |
| 81 | TBK1 | 0.78765356 |
| 82 | MST1R | 0.78529595 |
| 83 | PRKAA2 | 0.78402633 |
| 84 | JAK2 | 0.77973698 |
| 85 | MST4 | 0.77330746 |
| 86 | PBK | 0.75846021 |
| 87 | ZAP70 | 0.75099862 |
| 88 | EPHB2 | 0.74754377 |
| 89 | ALK | 0.74296793 |
| 90 | EGFR | 0.74055129 |
| 91 | MAP3K9 | 0.74032459 |
| 92 | MAP3K14 | 0.73902808 |
| 93 | NEK9 | 0.72909835 |
| 94 | MAP3K7 | 0.72553069 |
| 95 | CDC42BPA | 0.72546290 |
| 96 | FLT3 | 0.72193528 |
| 97 | MOS | 0.70799705 |
| 98 | CSK | 0.69068482 |
| 99 | FYN | 0.68270737 |
| 100 | IRAK4 | 0.67433897 |
| 101 | CSNK1A1L | 0.66395827 |
| 102 | MAP3K13 | 0.66164750 |
| 103 | TYRO3 | 0.65444377 |
| 104 | FGFR1 | 0.65075648 |
| 105 | MTOR | 0.64861470 |
| 106 | BRSK2 | 0.63808311 |
| 107 | ERBB3 | 0.63282454 |
| 108 | ERBB4 | 0.62212327 |
| 109 | HCK | 0.60620562 |
| 110 | CDK6 | 0.58610129 |
| 111 | PDK1 | 0.55721559 |
| 112 | MARK2 | 0.55468131 |
| 113 | SRC | 0.55386753 |
| 114 | SGK223 | 0.54668929 |
| 115 | SGK494 | 0.54668929 |
| 116 | IRAK2 | 0.54523871 |
| 117 | ITK | 0.54454828 |
| 118 | INSR | 0.53084742 |
| 119 | DAPK2 | 0.52404874 |
| 120 | BMPR2 | 0.51528210 |
| 121 | TAOK1 | 0.50423313 |
| 122 | SMG1 | 0.49123463 |
| 123 | PRKCE | 0.45679011 |
| 124 | MAP3K3 | 0.43739901 |
| 125 | PAK4 | 0.43315010 |
| 126 | IGF1R | 0.43239514 |
| 127 | CLK1 | 0.43104400 |
| 128 | PRKCQ | 0.42800898 |
| 129 | CAMKK1 | 0.42691910 |
| 130 | LIMK1 | 0.42636032 |
| 131 | NEK6 | 0.42479324 |
| 132 | ERBB2 | 0.42252351 |
| 133 | CDK12 | 0.41826834 |
| 134 | HIPK2 | 0.41132497 |
| 135 | TAOK3 | 0.40823981 |
| 136 | RAF1 | 0.39900357 |
| 137 | BLK | 0.37769687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.32951474 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.09375217 |
| 3 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.72722806 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 1.68309894 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.63447081 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57563723 |
| 7 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.50840718 |
| 8 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.50427228 |
| 9 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.49263767 |
| 10 | Amoebiasis_Homo sapiens_hsa05146 | 1.47464500 |
| 11 | Focal adhesion_Homo sapiens_hsa04510 | 1.46566758 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.37946021 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35460501 |
| 14 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33419895 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.31298130 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30951962 |
| 17 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28789209 |
| 18 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.27779620 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27111030 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23670507 |
| 21 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.21158617 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19528047 |
| 23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16901053 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.15775160 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15173953 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14109571 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.13405738 |
| 28 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12054210 |
| 29 | Thyroid cancer_Homo sapiens_hsa05216 | 1.10967139 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08280928 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07367344 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06425740 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06305295 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06225594 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05374156 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.04062558 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.01910050 |
| 38 | Mineral absorption_Homo sapiens_hsa04978 | 1.01445048 |
| 39 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.99630110 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98749459 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98618586 |
| 42 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98544484 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 0.98250373 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.98244766 |
| 45 | Glioma_Homo sapiens_hsa05214 | 0.98124405 |
| 46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.95475836 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95004817 |
| 48 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94867678 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94336575 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.94050071 |
| 51 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93842871 |
| 52 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.93842480 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92599374 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91967563 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89488349 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89435107 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88442557 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88226492 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87977175 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.87761265 |
| 61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86343010 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85425713 |
| 63 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84286612 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 0.83736458 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83051524 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83006567 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.82416860 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80005895 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.79983904 |
| 70 | Axon guidance_Homo sapiens_hsa04360 | 0.78917898 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77362706 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.77351978 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.76469271 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75638390 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75596368 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75569463 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75486085 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74910227 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74092713 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73749647 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.73738838 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73172915 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73088975 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.72909093 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72856402 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72002408 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71577362 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71157561 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70392847 |
| 90 | Legionellosis_Homo sapiens_hsa05134 | 0.70360699 |
| 91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70130615 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69991644 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.69893492 |
| 94 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68874472 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68538377 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67528646 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.66998702 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65732360 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.65611627 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.64191855 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63744506 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63696169 |
| 103 | Influenza A_Homo sapiens_hsa05164 | 0.63560131 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.63557765 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.63545345 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.63457740 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62752625 |
| 108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61210395 |
| 109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61075794 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59506380 |
| 111 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.59420151 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59320858 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59140941 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58517095 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57991622 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57821640 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.57701373 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57393407 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.57123605 |
| 120 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56921196 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56682915 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.56616403 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56179838 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56075438 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55774086 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55499895 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55453455 |
| 128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55422795 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55263982 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55143491 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55136681 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.55095507 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54561817 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54356364 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54157322 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.52680237 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52478193 |

